192 related articles for article (PubMed ID: 22161355)
1. Reducing systems biology to practice in pharmaceutical company research; selected case studies.
Benson N; Cucurull-Sanchez L; Demin O; Smirnov S; van der Graaf P
Adv Exp Med Biol; 2012; 736():607-15. PubMed ID: 22161355
[TBL] [Abstract][Full Text] [Related]
2. Why and how to expand the role of systems biology in pharmaceutical research and development.
Phair RD
Adv Exp Med Biol; 2012; 736():533-42. PubMed ID: 22161350
[TBL] [Abstract][Full Text] [Related]
3. Integration not isolation: arguing the case for quantitative and systems pharmacology in drug discovery and development.
Agoram BM; Demin O
Drug Discov Today; 2011 Dec; 16(23-24):1031-6. PubMed ID: 22020181
[TBL] [Abstract][Full Text] [Related]
4. Biomarker-based drug safety assessment in the age of systems pharmacology: from foundational to regulatory science.
Zhang C; Hong H; Mendrick DL; Tang Y; Cheng F
Biomark Med; 2015; 9(11):1241-52. PubMed ID: 26506997
[TBL] [Abstract][Full Text] [Related]
5. Effective integration of systems biology, biomarkers, biosimulation and modelling in streamlining drug development.
Krishna R; Schaefer HG; Bjerrum OJ
Eur J Pharm Sci; 2007 May; 31(1):62-7. PubMed ID: 17408933
[TBL] [Abstract][Full Text] [Related]
6. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
7. Genomics and transcriptomics in drug discovery.
Dopazo J
Drug Discov Today; 2014 Feb; 19(2):126-32. PubMed ID: 23773860
[TBL] [Abstract][Full Text] [Related]
8. Relevance of systems pharmacology in drug discovery.
Cucurull-Sanchez L; Spink KG; Moschos SA
Drug Discov Today; 2012 Jul; 17(13-14):665-70. PubMed ID: 22405899
[TBL] [Abstract][Full Text] [Related]
9. Translational research in the pharmaceutical industry: from theory to reality.
Sultana SR; Roblin D; O'Connell D
Drug Discov Today; 2007 May; 12(9-10):419-25. PubMed ID: 17467579
[TBL] [Abstract][Full Text] [Related]
10. Fundamental problems lie ahead in the drug discovery and commercialization process: restructuring of the pharmaceutical industry and an improved partnership with academia are required.
Brewer GJ
J Investig Med; 2006 Sep; 54(6):291-302. PubMed ID: 17191351
[No Abstract] [Full Text] [Related]
11. Early integration of pharmacokinetic and dynamic reasoning is essential for optimal development of lead compounds: strategic considerations.
Gabrielsson J; Dolgos H; Gillberg PG; Bredberg U; Benthem B; Duker G
Drug Discov Today; 2009 Apr; 14(7-8):358-72. PubMed ID: 19162219
[TBL] [Abstract][Full Text] [Related]
12. Cytomics and drug discovery.
Van Osta P; Ver Donck K; Bols L; Geysen J
Cytometry A; 2006 Mar; 69(3):117-8. PubMed ID: 16496374
[TBL] [Abstract][Full Text] [Related]
13. Towards quantitative biology: integration of biological information to elucidate disease pathways and to guide drug discovery.
Fischer HP
Biotechnol Annu Rev; 2005; 11():1-68. PubMed ID: 16216773
[TBL] [Abstract][Full Text] [Related]
14. The impact of systems approaches on biological problems in drug discovery.
Hood L; Perlmutter RM
Nat Biotechnol; 2004 Oct; 22(10):1215-7. PubMed ID: 15470453
[No Abstract] [Full Text] [Related]
15. Putting nature back into drug discovery.
Müller-Kuhrt L
Nat Biotechnol; 2003 Jun; 21(6):602. PubMed ID: 12776140
[No Abstract] [Full Text] [Related]
16. Systems biology approaches and tools for analysis of interactomes and multi-target drugs.
Schrattenholz A; Groebe K; Soskic V
Methods Mol Biol; 2010; 662():29-58. PubMed ID: 20824465
[TBL] [Abstract][Full Text] [Related]
17. Systems biology: an evolving approach in drug discovery and development.
Ho RL; Lieu CA
Drugs R D; 2008; 9(4):203-16. PubMed ID: 18588352
[TBL] [Abstract][Full Text] [Related]
18. Minimizing metabolic activation during pharmaceutical lead optimization: progress, knowledge gaps and future directions.
Kumar S; Kassahun K; Tschirret-Guth RA; Mitra K; Baillie TA
Curr Opin Drug Discov Devel; 2008 Jan; 11(1):43-52. PubMed ID: 18175266
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers: a valuable tool in clinical research and medical practice.
Carini C
IDrugs; 2007 Jun; 10(6):395-8. PubMed ID: 17642003
[TBL] [Abstract][Full Text] [Related]
20. Towards the virtual human patient. Quantitative Systems Pharmacology in Alzheimer's disease.
Geerts H; Spiros A; Roberts P; Carr R
Eur J Pharmacol; 2017 Dec; 817():38-45. PubMed ID: 28583429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
